300661:SZSESG Micro Corp. Class A Analysis
Data as of 2026-09-01 - not real-time
CN¥112.58
Latest Price
8/10Risk
Risk Level: High
Executive Summary
At ¥112.58, SG Micro Corp shows no decisive moving-average alignment, leaving the trend neutral. Across the trailing 30 sessions it gained 2.3%. Relative strength is 49.5 — neutral — and the MACD signal is bearish. Recent trading has carved out support near ¥98.87 and resistance around ¥123.80.
Valuation screens as overvalued: a P/E of 92.3 sits above the sector average of 35.8. Analyst price targets sit 13.8% above the current price. Revenue is growing at 45.5% on a 16.4% profit margin. The 0.18% dividend yield looks covered by current payout levels.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 74.7%, a beta of 0.90 and a maximum drawdown of 37.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Valuation screens as overvalued: a P/E of 92.3 sits above the sector average of 35.8. Analyst price targets sit 13.8% above the current price. Revenue is growing at 45.5% on a 16.4% profit margin. The 0.18% dividend yield looks covered by current payout levels.
The composite risk read is 8/10, putting it in high territory. With 30-day volatility of 74.7%, a beta of 0.90 and a maximum drawdown of 37.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading above the 200-day average of 89.33
- MACD momentum is negative
- 30-day volatility of 74.7%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 92.3 versus sector average of 35.8
- Trading above the 200-day average of 89.33
- Analyst targets imply +13.8% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 92.3 versus sector average of 35.8
- Analyst targets imply +13.8% versus the current price
- Profit margin of 16.4% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth45.50%
Profit Margin16.40%
P/E Ratio92.3
ROE10.48%
ROA4.32%
Debt/Equity5.84
P/B Ratio12.8
Op. Cash FlowCN¥608.4M
Free Cash FlowCN¥-228820464
Industry P/E35.8
Technical Analysis
TrendNeutral
RSI49.5
SupportCN¥98.87
ResistanceCN¥123.80
MA 20CN¥114.14
MA 50CN¥115.78
MA 200CN¥89.33
MACDBearish
VolumeDecreasing
Fear & Greed Index93.64
Valuation
Fair ValueCN¥30.81
Target PriceCN¥128.16
Upside/Downside13.84%
GradeOvervalued
TypeGrowth
Dividend Yield0.18%
Risk Assessment
Beta0.90
Volatility74.74%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.